Hansberger Global Investors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$37.5M Buy
4,339,985
+4,185,225
+2,704% +$35.2M 10.57% 5
2014
Q1
$1.36M Hold
154,760
0.33% 32
2013
Q4
$1.27M Sell
154,760
-343,640
-69% -$2.72M 0.28% 33
2013
Q3
$3.77M Buy
498,400
+32,405
+7% +$236K 0.72% 13
2013
Q2
$3.52M Buy
+465,995
New +$3.4M 0.78% 12

Other funds holding RDY

Hansberger Global Investors's RDY Position: Q2 2014 in Review

Hansberger Global Investors increased its Dr. Reddy's Laboratories (RDY) stake by 2,704% in Q2 2014, buying an estimated $35.2M and bringing the position to 4,339,985 shares worth $37.5M. The position accounts for 10.57% of the portfolio, ranked #5.

Hansberger Global Investors first reported a position in RDY in Q2 2013 and has held it in 5 quarters since. 169 funds tracked by Wall St. Rank hold RDY as of Q2 2014.

  • Hansberger Global Investors held 4,339,985 shares of Dr. Reddy's Laboratories worth $37.5M as of Q2 2014.
  • Hansberger Global Investors bought 4,185,225 Dr. Reddy's Laboratories shares in Q2 2014, an estimated $35.2M.
  • Dr. Reddy's Laboratories made up 10.57% of Hansberger Global Investors's portfolio in Q2 2014, its #5 holding.
  • Hansberger Global Investors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 5 quarters since.
  • 169 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2014.

Based on Hansberger Global Investors's 13F filing for Q2 2014, filed 15 Jul 2014.